LS39: Utilization method of electronic data submitted for J-NDA filing
Senior Regulatory Scientist, Therapeutic Area Regulatory,
Eli Lilly Japan K.K., Japan
Office of Advanced Evaluation with Electronic Data
Pharmaceuticals and Medical Devices Agency, Japan
Manager, Regulatory Strategy Group 2, Regulatory Affairs
Pfizer R&D Japan G.K., Japan
Have an account?